🟢 HCW Biologics is trading 5.66% up in after-hours trading; with no reliable company-specific explanation

HCW Biologics is trading 5.66% up at $2.24 after closing at $2.12 on August 20, 2026, with no reliable company-specific announcement explaining the after-hours rebound.

• The regular session decline followed broader biotech weakness, with XBI reportedly down 2.47% and rising Treasury yields pressuring risk assets.
• A 581,047-share lock-up expired on August 20.
• Recent quarterly results were released August 14.